India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
At least one recognised startup in every State and UT; spread across over 80% of districts
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
Subscribe To Our Newsletter & Stay Updated
